Background: Resveratrol (RES) inhibits cell growth, induces apoptosis and augments
chemotherapeutics in multiple cancer types, although its effects on drug-resistant cancer …

It was reported recently that resveratrol could sensitise a number of cancer cell lines to the
anticancer actions of several other cancer drugs, including paclitaxel. In the present study …

Although its mechanisms remain unidentified, resveratrol (trans‑3, 4', 5‑trihydroxystilbene;
RES), which is an active, low molecular-weight compound, possesses a unique antitumor …

Multidrug resistance (MDR) to anticancer drugs remains a serious obstacle to the success of
cancer chemotherapy. Resveratrol, a polyphenol, present in natural products exerts …

Objectives: Resveratrol, with its robust antioxidant activity, has frequently been suggested as
potentially having activity in cancer prevention and some recent reports have indicated that it …

Resveratrol (RES), a polyphenol compound with anti‑proliferative properties, has been
previously evaluated for its beneficial effects against a variety of tumour cells. The current …

Background Multidrug resistance is a major problem in the treatment of breast cancer, and a
number of studies have attempted to find an efficient strategy with which to overcome it. In …

As breast cancer cells often develop chemoresistance, better therapeutic options are in
search to circumvent it. Here we demonstrate that human epidermal growth factor receptor-2 …

Breast cancer is one of the leading fatal diseases for women worldwide who cannot have
surgery typically have to rely on systemic chemotherapy to extend their survival. Doxorubicin …

A multidrug-resistant clone of human oral epidermoid carcinoma KB cells was isolated by
stepwise selection on exposure to increasing doses of vincristine. The final clone, KBv200 …